02 August 2026
Die Erforschung neuer Antibiotika-Varianten steht vor zahlreichen Herausforderungen. Im Juli ist ein millionenschweres Projekt gestartet, um die Entwicklung neuer Medikamente zu beschleunigen. Die Forschenden, unter anderem vom DFKI und HIPS, nutzen dafür Künstliche Intelligenz.
In addition to technically necessary cookies, this website uses the web analytics software Matomo. To help us improve user experience, we use Matomo to analyse how visitors interact with the website. Matomo runs on a university server. Your data will be stored for a period not exceeding six months and will not be disclosed to third parties. Your IP address cannot be used to identify you. For more information please refer to the university's privacy notice.
Information for
Quick links
Faculties
